Hematology NewsRisk index stratifies pediatric leukemia patients undergoing HSCTJune 8, 2020AMLALLLeukemia, Myelodysplasia, TransplantationTransplant
Hematology NewsAcute lymphoblastic leukemia can be successfully treated in the frail elderlyJune 3, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsUniversal CAR-T therapy produces CRs in relapsed/refractory T-ALLMay 19, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCD123 may be a marker for residual disease and response evaluation in AML and B-ALLMay 15, 2020AMLALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsSecondary acute lymphoblastic leukemia more lethal than de novoMay 14, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCOVID-19: Adjusting practice in acute leukemia careApril 1, 2020COVID-19 UpdatesALLAML
Hematology NewsSecond transplant a good salvage option for children with ALL, AML, or MDSMarch 16, 2020TransplantALLAMLMyelodysplastic Syndrome
Hematology NewsPhase 2 data: Inotuzumab, approved in adults with B-ALL, shows promise in kids, tooFebruary 11, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPhase 2 study shows regimen benefit with dasatinib in Ph+ALL therapyJanuary 22, 2020ALLTransplantation
Hematology NewsUKALL14: Rituximab improves EFS in B-ALL, but four doses not enoughJanuary 15, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPromising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemiaJanuary 15, 2020ALLLeukemia, Myelodysplasia, TransplantationPediatrics
Hematology NewsChemo-free induction-consolidation protocol for Ph+ ALL improved survivalJanuary 14, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsHigh response, survival rates with ponatinib/hCVAD in Ph-positive ALLJanuary 8, 2020ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020ALLT Cell LymphomasCellular TherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncology
